The answer so far

BPC-157 has produced interesting findings in animal injury experiments, including a study of deliberately cut Achilles tendons in rats. That does not establish that it heals a human tendon or shortens recovery. A small human knee-pain report described symptom improvement, but it had no control group and did not demonstrate tendon repair on follow-up scans.12

On this page
  1. Why are people interested in this?
  2. What happened in the rat Achilles study?
  3. Why does the difference between an animal model and my injury matter?
  4. What did the knee-pain report show?
  5. What would a convincing tendon study measure?
  6. What if I have an injury now?
  7. Sources
LINKED BUILDING BLOCKSAmino acids joined into a chainSequence and structure both matter
Conceptual schematic. Simplified and not to scale; not a scan, microscopy image or validated simulation.

Why are people interested in this?

A tendon is a tough band of tissue that connects muscle to bone. An Achilles injury can affect walking, running or exercise, and a slow recovery can make a proposed repair peptide sound appealing. Some laboratory and animal studies have investigated whether BPC-157 changes processes involved in tissue repair. That is a reason to ask a research question, not a guarantee about a person’s injury. For the broader picture, see the BPC-157 profile.12

What happened in the rat Achilles study?

In a 2003 experiment, researchers surgically cut Achilles tendons in rats and compared BPC-157 with saline. They reported differences in measures including tendon strength, function and tissue appearance over the study period. They also examined tendon cells in a laboratory. These observations are worth understanding on their own terms: they describe a controlled animal injury and cells, not a trial of a commercial product in people. We reviewed the study abstract, not the full paper.

The abstract reports that the rats received the substances by intraperitoneal injection, into the abdominal cavity; that route in a rat does not establish effects or safety of an injection in a person.1

From a tendon question to the evidenceA conceptual map: these studies involve different subjects and outcomes.
  • In the laboratoryTendon cells can be studied outside a living body.
  • In ratsAn Achilles-tendon experiment reported changes in strength, function and tissue appearance.
  • In peopleA small knee-pain report recorded recalled symptoms, without a placebo group or follow-up scans proving repair.
  • The unanswered questionA controlled human tendon study would need to measure meaningful recovery and harms.

Why does the difference between an animal model and my injury matter?

A surgically cut rat tendon is not necessarily comparable to a person’s gradual overuse injury, partial tear or complete rupture. Species, injury, timing, route, formulation and rehabilitation can all change the question. An animal result may justify better human research, but it does not tell us whether a given product reaches an injured human tendon, produces meaningful recovery or is safe. Wondering whether it needs to be used near an injury? See what route research can and cannot tell us.12

What did the knee-pain report show?

A retrospective report contacted 16 people treated for different kinds of knee pain; 12 had received BPC-157 alone. Eleven of those 12 reported improvement, but there was no placebo group, follow-up varied, and the outcome relied on recalled symptoms. The report did not present follow-up MRI evidence showing tendon or other tissue repair. Pain can improve for several reasons and is not the same outcome as documented tendon healing. Read the full human-evidence guide. Follow the knee-pain study and the “11 out of 12” claim.32

What would a convincing tendon study measure?

Researchers would need to define the injury and exact preparation, compare it with appropriate care or placebo, and follow enough people for long enough. Meaningful outcomes might include pain, ability to use the limb, return to activity and adverse effects; imaging or other assessments could address tissue structure. A change in one measure does not automatically establish every other outcome. A mixture with TB-500 is a further separate question: compare BPC-157 and TB-500. For a separate oral collagen study in people with chronic Achilles pain, see collagen and tendon recovery.2

What if I have an injury now?

A clinician or physiotherapist can help assess the actual injury and discuss an appropriate recovery plan. Sudden Achilles pain with a snap or difficulty walking or rising on the toes can indicate a rupture and needs urgent assessment; do not wait for a research claim to resolve that question. If a peptide product has caused a reaction, see when to seek help for a reaction. If you are unsure what tissue might be involved, start with tendons, ligaments, muscles and recovery.45

Sources, kept close.

Selected supporting sources; this is not a complete literature review.

  1. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendonJournal of Orthopaedic Research / PubMed · Original rat tendon and cell study; abstract reviewedAccessed 2026-11-05 · Source date: 2003
  2. Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safetyPeer-reviewed systematic review / PubMed · Systematic review; very low certainty evidenceAccessed 2026-11-03 · Source date: 2026
  3. Intra-Articular Injection of BPC 157 for Multiple Types of Knee PainLee and Padgett / Alternative Therapies in Health and Medicine · Published retrospective uncontrolled case series; full report inspectedAccess checked 2026-11-05 · Source date: 2021 · Full paper: 16/17 contacted, 12 received BPC-157 alone and four also received thymosin beta-4; recall-based, no control, no follow-up MRI; patients paid.
  4. Achilles tendinopathyMersey Care NHS Foundation Trust · UK public health guidance; not BPC researchAccessed 2026-11-05
  5. CellulitisNHS · Official clinical guidanceAccessed 2026-11-07